Chapter 65: Management of Patients with Oncologic or Degenerative Neurologic Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we're tackling something that can feel pretty overwhelming for a lot of students and clinicians.

We're taking on the huge clinical challenge of managing oncologic and degenerative neurologic disorders.

That's right, and our whole mission today is to give you a really solid shortcut, you know, a clear path through the material in chapter 65 of Brenner and Sutterth's.

Right, we're pulling out just the essentials, the stuff you absolutely have to know from assessment all the way to those really complex nursing interventions.

Exactly, because these conditions are often chronic, they're life altering, and they require a really specific kind of care.

Yeah, and the chapter breaks it down pretty logically into two main areas, and we're just going to follow that structure today.

We are.

First, we're going to get into the oncologic disorders, so think brain and spinal cord tumors.

Okay.

And then second, we'll shift gears into the big category of degenerative neurologic disorders.

So that's where we'll see Parkinson's, ALS, Huntington disease.

Yeah, all of those, plus muscular dystrophies and degenerative disc disease.

And the goal is to really connect the dots between the, you know, the dense science and what you actually do at the bedside.

Perfect.

But before we jumped in, let's nail down five key terms.

This is our, uh -huh,

glossary, the vocabulary you'll need to really get what we're talking about today.

Okay, let's do it.

First up, from the movement disorder world is bradykinesia.

Bradykinesia.

I want to be really clear.

This isn't just slow movement.

It's the abnormally slow initiation and then the execution of voluntary movements.

So the getting started part is the problem.

That's the huge part of it.

The difficulty in starting to move, like you said, rising from a chair or that classic slow deliberate shuffle.

It is a cardinal, I mean a cardinal sign of Parkinson's disease.

Okay.

So what about the other end of that spectrum, the term Korea?

Korea is.

It's dramatic.

It's these rapid, jerky, involuntary movements.

They're writhing and they have no purpose.

And it often includes facial grimacing.

Yes, very noticeable facial grimacing.

When you see Korea, your mind should immediately jump to Huntington disease.

It's this relentless, almost high energy, uncontrollable movement.

Got it.

Now, speaking of Parkinson's, we hear the term dyskinesia a lot, especially with medications.

Right.

So dyskinesia is an impaired ability to execute voluntary movements.

But what we see clinically, you know, in the context of PD is often this uncontrollable rhythmic jerking.

Like head bobbing.

Head bobbing, facial grimacing, movements of the limbs.

And the really tough part is that it's a side effect of long -term levodopa therapy.

The very drug that's supposed to be helping.

Exactly.

It becomes a huge management challenge for us down the line.

Okay.

Let's shift gears to the oncologic side, the term papildema.

Papildema.

So this is swelling or edema of the optic nerve head.

You can see it on a fundoscopic exam.

And why is that so critical for us to know?

Because it is one of the classic crucial signs that tells you intracranial pressure, or ICP, is significantly elevated.

It's a red flag that demands immediate attention.

Okay.

And our last one for the degenerative spine,

spondylosis.

Spondylosis is really just the big umbrella term for all those degenerative changes, the wear and tear, you know, the changes that happen in the disc and in the vertebral bodies right next to it.

It's the basic problem that leads to most chronic neck and back pain.

And we usually see it in the cervical or lumbar spine.

Yeah.

Those are the most common spots.

Okay.

With those terms locked in, let's start part one.

Oncologic disorders of the brain and spinal cord.

We have to begin with brain tumors.

Right.

And the central issue, the absolute core of the problem is physics.

It comes down to the skull.

It's a rigid box.

It's a completely rigid, unyielding box.

And the contents inside, the brain tissue, the cerebrospinal fluid, the blood, they all exist in this delicate equilibrium.

That's the Monroe -Kelly hypothesis.

And a tumor just throws a wrench in that whole system.

A huge wrench.

It's a new mass.

It has to take up space.

And to do that, it has to displace something else.

And that immediately violates that equilibrium.

So let's really unpack that.

What's the physiologic cascade that happens when that confinement is violated?

The tumor causes damage in three main ways.

There's direct compression of brain tissue.

Okay.

Then there's the inflammation and swelling around it, what we call paratumoral edema.

And finally, it can actually infiltrate or grow into the normal tissue.

And that all leads to?

It leads to a cascade of disasters.

You get increased ICP.

You get cerebral edema.

You get focal neurologic signs that tell you exactly where the tumor is pressing.

And seizures.

And seizures, absolutely.

If you don't intervene, that mass effect will eventually compress the brain stem, which controls all your vital functions like breathing.

And that leads to herniation and death.

So it's obviously critical to know where the tumor came from.

Let's talk about primary versus secondary tumors.

Absolutely essential distinction.

Primary brain tumors start from cells inside the brain, usually glial cells.

And they don't spread outside the brain.

Almost never.

They rarely, if ever, metastasize outside the central nervous system.

And it's important to note the textbook really emphasizes that exposure to ionizing radiation is the only known modifiable risk factor for these primary tumors.

Okay.

So what about the secondary ones, the ones that start somewhere else and travel to the brain?

Those are the secondary or metastatic tumors.

And this is a huge clinical problem because they are about twice as common as primary tumors.

Wow.

And where do they usually come from?

Most commonly from lung cancer, breast cancer, melanoma, or from the GI tract.

And, you know, we're actually seeing more of them.

Why is that?

It's sort of a strange consequence of success.

Modern cancer treatments are letting patients with systemic cancers live much longer, which unfortunately gives the cancer more time to potentially metastasize to the brain.

That makes sense.

So if we were to look at a chart, like chart 65 -1 that breaks down the classifications, what are the big groups we need to know?

You can kind of map them out mentally.

The biggest category by far is intracerebral tumors, and those are dominated by the gliomas.

And gliomas are tough because they infiltrate.

Right.

They don't have nice clean borders.

Exactly.

They grow rapidly.

They have these little tentacles that reach into the surrounding brain tissue, which makes them exceptionally difficult to treat.

And the grading of these gliomas, that tells us how malignant they are.

Precisely.

We grade the astrocytomas from grade the first, which is the least aggressive, all the way to grade the earth.

And grades the third and four are the glioblastomas.

That's right.

The notoriously aggressive glioblastomas.

They are highly malignant, they're deeply infiltrating, and they resist almost all of our treatments.

Complete surgical removal is just impossible without causing, you know, catastrophic neurologic damage.

The textbook mentions oligodendrogliomas specifically.

Why are they significant?

They're worth noting because they show a much greater sensitivity to chemotherapy compared to the astrocytomas.

And that's a game changer.

It fundamentally alters our treatment approach and the conversations we have with patients about their prognosis.

Okay.

So that's inside the brain tissue itself.

What about tumors that come from the supporting structures around the brain?

Right.

So the most common benign tumor in that category is the meningioma.

And that's a huge percentage of primary tumors, isn't it?

It is a massive 37 % of all primary brain tumors.

And they're different.

They are usually encapsulated, they're slow growing, and they tend to occur in middle -aged women.

So their effect is more from compression than invasion.

Exactly.

It's pure compression.

But, and this is a big but, even though it's benign, its location can make it incredibly dangerous.

If it's near the optic nerve or at the base of the skull, getting it out surgically is a huge challenge.

And then there's the acoustic neuroma.

The acoustic neuroma or schwannoma.

It grows on the eighth cranial nerve, the one for hearing and balance.

So the symptoms would be hearing loss and vertigo.

Right.

The problem is they can get pretty big before the symptoms become really obvious.

And managing them is tricky.

It's a balance between surgery and sometimes just watching and waiting or using highly focused stereotactic radiation.

I think we should really do a deep dive on pituitary adenomas because they have this unique dual action problem, the pressure effects and the hormonal effects.

Absolutely.

They're fascinating and complex.

They're almost never malignant, but their location is prime rilordate.

They sit right under the optic chiasm where the optic nerves cross.

So vision is immediately at risk.

Immediately.

Let's talk about the pressure effects first.

As that adenoma grows, it presses directly on those optic nerves.

And what's the classic visual sign the nurse should look for?

You're looking for visual field deficits.

Often it's a loss of the peripheral vision in both eyes.

What we call bi -temporal hemianopsia, like wearing blinders.

And they'll have severe headaches too.

Severe headaches from the local tension.

And if it keeps growing, it can start pushing up and causing hypothalamic dysfunction.

Which would affect sleep, appetite.

Sleep, appetite, temperature regulation,

even emotional stability, all of that, plus the signs of rising ICP.

Okay.

So that's the pressure.

Now the hormonal effects, it's basically endocrine chaos.

It really is.

About half of these tumors are functioning.

Meaning they are actively secreting way too much of a certain hormone.

Like prolactinomas.

Exactly.

They secrete excess prolactin.

In women, that leads to amenorrhea loss of periods and galacturia, which is milk production.

In men, it causes impotence and hypogonadism.

Often these are the symptoms that lead to a diagnosis before the tumor gets huge.

And what about excess growth hormone, GH or ACTH?

If the tumor overproduces GH in an adult, you get acromegaly.

And this is a very noticeable chronic condition.

You see enlargement and distortion of their facial features, their hands, their feet.

It's often painful because of nerve entrapment.

And if it's ACTH?

Too much ACTH leads to Cushing's disease.

And you'll see all the classic signs.

That central obesity with thin limbs, the moon face, the buffalo hump, purple striae on the abdomen, hypertension, and chronically high blood sugar.

So as a nurse, you're managing a brain tumor and a severe endocrine disorder at the same time.

At the exact same time, it's the definition of interdisciplinary care.

So let's tie these clinical signs back to specific tumor locations because a good neuro exam can really start to map out where the problem is.

It can.

So we know the generalized symptoms are from that high ICP, the headache that's worse in the morning, sometimes that projectile vomiting that comes without nausea, and the papildema we mentioned.

Right.

But the localized signs, that's the real map to the lesion.

Okay, so if a tumor is in the frontal lobe, what might a family member be the first to notice?

This can be one of the most tragic things to watch.

The frontal lobe is your executive function, your judgment, your personality.

So profound personality changes.

Profound apathy, impulsivity, losing their inhibitions, sometimes saying or doing really inappropriate things.

And then physically, you might see weakness or hemiparesis on the opposite side of the body.

Okay, what about the cerebellum?

The cerebellum is the brain's engine of coordination.

So if it's damaged, you're going to see dizziness and an ataxic or staggering gait.

The classic drunk walk.

Exactly.

People often describe it that way.

And they tend to fall toward the side of the tumor.

You also want to look for nystagmus, those involuntary rhythmic eye movements.

We talked about acoustic neuromas earlier.

What's the classic progression of symptoms for a tumor in that cerebellar panettine angle?

It's a really clear sequence of cranial nerve compression.

It starts with cranial nerve 8.

Hearing imbalance.

Right, so you get hearing loss, tinnitus, and vertigo first.

As the tumor gets bigger, it starts to press on cranial nerve 5.

The trigeminal nerve.

So the patient will start to feel numbness, tingling, or even pain in their face.

And then only later, as it grows even more, does it hit cranial nerve 7, causing facial weakness or paralysis.

So recognizing that sequence hearing, then face sensation, then face movement is key.

It's absolutely essential for an early diagnosis.

This brings us to diagnosis, medical, and surgical management.

So once we have these suspicions, how do we confirm them?

The diagnosis really comes from a combination of the patient's history, a really detailed neuro exam, and of course, advanced imaging.

And the gold standard for imaging is the MRI.

The MRI scan is the single most full diagnostic tool we have, no question.

It's just superior for visualizing soft tissue.

It can see smaller lesions.

And it's especially good for tumors that are close to thick bone, like in the brain stem or the pituitary fossa.

So where does a CT scan fit in?

What does it add?

A CT scan, especially with contrast, gives us really specific data.

It tells us the number of lesions, their exact size, their density.

And it's fantastic for showing the amount of surrounding cerebral edema.

And for seeing hydrocephalus quickly.

Very quickly.

It's great for evaluating the ventricles.

Now for tumors that are really deep and hard to get to, the book talks about stereotectic biopsy.

It sounds like something out of science fiction.

How does it work?

It's an incredible piece of technology.

So the patient is fitted with this rigid three -dimensional frame that's fixed to their skull.

Then using computer -assisted imaging, CT, MRI, you name it, the surgeon creates a 3D map of the patient's brain.

This map lets them guide a needle through a tiny little burr hole with pinpoint accuracy to get a tissue sample from a very deep tumor.

And it does this while avoiding all the critical structures around it.

Precisely.

It can even be used to deliver localized treatment, not just for biopsy.

And what if you want to know how aggressive the tumor is, functionally speaking?

That's where a PETE scan comes in.

A PETE scan is used to grade the malignancy based on its metabolic activity.

So a low -grade tumor wouldn't be using much energy.

Right.

They often show hypometabolism.

They aren't gobbling up a lot of glucose.

But a high -grade aggressive tumor like a glioblastoma, it lights up on the scan.

It shows marked hypermetabolism.

And that functional difference is critical for planning treatment.

Vital for determining how aggressive our treatment needs to be.

So once we have the diagnosis, it's an all -hands -on -deck interdisciplinary approach.

Let's start with the immediate medical and pharmacologic strategies.

How do we manage that life -threatening cerebral edema?

The first and often life -saving drug we give is a high -dose corticosteroid, usually dexamethasone.

And it works by reducing the inflammation around the tumor.

It dramatically reduces that paratumoral inflammation and edema.

And the effect can be rapid.

You can see a patient's severe headache and declining level of consciousness improve remarkably quickly.

And what about getting fluid out of the brain itself?

For that, we use osmotic diuretics.

The big ones are mannitol, or sometimes hypertonic saline.

They literally pull fluid out of the brain tissue, reducing the total fluid content and lowering that dangerous ICP.

And of course, you have to control seizures.

Mandatory.

We almost always use anti -epileptic drugs like levotiracetam, prophylactically, or for active seizures.

Now, when it comes to chemotherapy,

what's the single biggest biological hurdle we face?

The blood -brain barrier, without a doubt.

It's this highly selective membrane that protects the brain, but it also keeps out most of our effective chemotherapy drugs.

So you can't get a high enough dose to the tumor without poisoning the rest of the body.

Exactly.

You can achieve a therapeutic concentration in the brain without causing catastrophic systemic toxicity.

The main exception the text mentions is oral temozolomide.

It actually can cross that barrier, and it's the standard of care for gliomas.

And you mentioned a newer option for glioblastomas.

Yes.

It's called tumor treating fields, or TTF.

It's a non -pharmacologic approach where the patient wears a cap -like device on their head.

And it generates electric fields.

Alternating electric fields, yeah.

The idea is that these fields disrupt the process of mitosis or cell division,

specifically in the rapidly dividing tumor cells.

So it's a constant therapy.

What does the nurse need to watch for?

It is a constant day -to -day therapy.

The main side effect we see is skin irritation under the electrodes of the device.

Okay.

Let's move on to the surgical and radiation options.

For a malignant tumor like a glioblastoma where a cure isn't possible, what's the main goal of surgery?

The goal is maximal safe resection.

That means removing as much of the tumor as you possibly can.

We call it debulking.

Without making the patient's existing neurologic deficits any worse.

And why is debulking so important?

It relieves the immediate pressure.

And theoretically, it leaves fewer tumor cells behind to develop resistance to the radiation or chemotherapy that will follow.

And for benign tumors like meningiomas or pituitary adenomas?

For a meningioma, we'd do a craniotomy to remove it.

For a pituitary adenoma, the approach is often transfenoidal.

They go up through the nose and sphenoid sinus, which avoids having to open the skull and expose the brain at all.

So radiation.

External beam is sort of the standard.

But the book talks about stereotactic radio surgery, like the gamma knife.

Explain how that's so much more precise.

It's like the ultimate form of target practice.

Using that same precise 3D mapping from the stereotactic frame, the machine aims hundreds of narrow, low -dose beams of radiation at the tumor.

And each individual beam is too weak to cause damage on its way in.

That's the key.

Each beam is harmless to the tissue it passes through.

But where all those beams converge, precisely on that deep, inaccessible tumor, they deliver an incredibly high, focused dose of radiation.

Often in a single session, without an incision.

Exactly.

The big trade -off, the main risk, is the potential for delayed radiation necrosis, or tissue death, in the healthy brain tissue right around the target.

Which brings us to where the rubber meets the road, the nursing process for a patient with a brain tumor.

Right.

And for many of these patients, especially with high -grade gliomas or extensive metastases, the reality is that our care is palliative.

It's focused on quality of life and symptom control.

So in our assessment, beyond the standard neurocheck, what are the key quality of life symptoms we need to zero in on?

We have to focus on what's causing the most distress.

That's usually pronic pain, respiratory issues, bowel and bladder problems, and major sleep disturbances.

And critically, we have to assess their nutritional status.

Because of cachexia.

Because of cachexia, that generalized muscle wasting and weight loss.

We need to be calculating BMI, looking at their lab values, like albumin, and getting a good dietary history.

And why is assessing the caregiver so important in this specific population?

It's absolutely vital.

These are long -draining diseases.

They take a huge emotional and financial toll on the family.

So we have to formally assess the caregiver for their level of stress, for financial strain, for how their roles have changed.

Their ability to cope directly impacts the patient's quality of life at home.

So based on that assessment, what are some of the high -priority nursing diagnoses we'd see?

You'll definitely see impaired self -care because of motor or cognitive decline.

You'll see impaired nutritional status.

And remember, that can be a deficit from cachexia or an excess from steroid -induced appetite.

Right.

And of course, severe anxiety about the prognosis and interrupted family process.

And the two big complications we are always, always monitoring for are seizures and uncontrolled headaches.

So when we're planning our interventions, how do we help the patient maintain some autonomy when they're facing this progressive decline?

The whole philosophy is to encourage independence for as long as humanly possible.

We help them set small, achievable goals every day.

That gives them a sense of mastery and contribution.

And using the whole in a professional team.

Aggressively.

We get PT and OT involved right away for exercise plans to maintain strength and range of motion.

It's all about slowing that inevitable decline.

How do we improve their nutrition, especially when they feel sick from treatment?

Timing is everything.

You plan their meals for when they're most rested and their pain is well controlled.

Make sure they have good oral hygiene before they eat to stimulate their appetite.

And if oral intake just isn't possible anymore.

You have to have the tough conversations about tube feeding.

You do.

You have to address nutritional support, whether it's a feeding tube or parenteral nutrition.

But it must be consistent with the patient's advanced directives and their end of life wishes.

Let's hit that steroid alert again.

For patients on high dose dexamethasone, what are the two big nursing concerns?

Okay, two things you have to watch for.

First is weight gain from increased appetite.

But second, and more critically, is the risk of hyperglycemia.

The steroids can really spike their blood sugar.

So we need to be doing regular blood glucose monitoring?

Diligently.

They may even need insulin or oral hypoglycemics.

And you have to educate the patient and family about managing their carbohydrate intake.

And what about the immense psychosocial burden?

How do we help patients and families relieve that profound anxiety?

We provide a compassionate, continuous presence.

Sometimes it's just about taking the time to sit and listen, using really open communication, and just acknowledging their fear and their sadness.

So it's not always about having the right words?

Often it's not.

Non -verbal communication, like a comforting touch, can be incredibly powerful.

We also try to help them focus on problem -based coping, empowering them with information, and connecting them to support groups like the American Brain Tumor Association.

To wrap this section up, let's summarize the key points of home care and transitional planning, which is detailed in chart 65 .2.

This planning has to start on day one.

The patient and family need to be educated on the impact the tumor will have on their daily life.

On their roles.

They need to understand the complex medication schedules, the dose, the timing, the side effects.

And a huge piece is the early introduction of supportive services.

So you're saying don't wait until the very end to talk about palliative care or hospice?

Never.

That's a huge mistake.

For a patient with an aggressive disease, those resources should be brought in early.

Palliative care is about comprehensive symptom management throughout the illness, and it ensures the patient can have a death with dignity, one that's consistent with their own wishes.

Okay, let's move down the CNS to spinal cord tumors.

How do we classify these anatomically?

We classify them based on where they are in relation to the spinal cord itself.

So they can be intramedullary, which means inside the cord tissue.

Those are rare, often gliomas.

Okay.

Or they can be extramedullary outside the cord.

And those can be either inside the dura or outside the dura.

Which of these are the most common and cause the most emergencies?

The vast majority of spinal tumors are secondary, meaning they're metastases, and they are usually extramedullary, extradural.

They grow outside the dura and they grow fast, compressing the cord and the nerve roots.

So what's the first symptom a patient usually reports?

Pain.

Pain is the cardinal sign.

It can be a localized pain right at the level of the tumor, or it can be a shooting, ridiculous pain that follows a nerve.

And that's followed by weakness.

Yes.

Weakness, a progressive loss of motor function, and this is key.

A loss of reflexes and sensation below the level of the tumor.

And of course, loss of bowel and bladder function is a very ominous sign of severe compression.

Given how fast that compression can happen, what is the management priority for these metastatic tumors?

This is a neurologic emergency.

The standard initial treatment is high -dose dexamethasone to get the swelling down fast.

That's often combined with urgent radiation therapy, which can be very effective for pain relief.

And when would they do surgery?

Emergent surgery is really reserved for when a patient has a sudden, profound loss of function.

You have to go in and decompress the cord immediately before that damage becomes permanent.

OK, let's focus on the nursing management.

Preoperatively, what is the single most important technique we have to teach the patient about moving?

Log rolling, without a doubt.

The patient has to be turned as a single, solid unit.

Shoulders, spine, and hips all move together.

Perfectly aligned.

No twisting, no bending, no flexing of a spine at all.

Any of those movements could cause catastrophic instability and more cord damage.

We also have to be assessing their respiratory status, especially with high cervical tumors.

And postoperatively, what are we monitoring for with every single check?

We're doing frequent, detailed neurologic checks.

Any sudden new motor or sensory deficit is a huge red flag.

It could mean the cord is ischemic, or there's new swelling, and the surgical team needs to know immediately.

And how do we assess that sensory level?

We do it systematically.

We gently pinch the patient's skin, starting low and moving up their body, asking them where they can feel it.

What about complications of the surgical site itself?

We're watching that dressing like a hawk for any sign of a CSF leak.

So that would be clear.

Or serosanguineous drainage.

Or if the incision starts to bulge, that could suggest a pseudomeningocell, a collection of CSF under the skin.

And if it was a cervical surgery, we're worried about the airway.

Always.

Swelling in the neck can compress the trachea, so we're monitoring their respiratory rate, their effort, listening for any stridor.

Okay, that's a great overview.

Let's transition now to part two.

Degenerative disorders.

And we have to start with the big one.

Parkinson's disease.

Yes, PD.

A chronic progressive movement disorder that affects millions of people.

It's caused by the progressive destruction of the dopamine -producing cells in a part of the brain called the substantia nigra.

And the symptoms don't even show up until a lot of the damage is already done.

That's the tragic part.

Symptoms typically don't begin until someone is in their 50s or 60s.

But by that point, the disease process has been silently underway for years.

The textbook has a great visual.

Figure 65 -3.

Can you walk us through that core pathophysiology, the imbalance between dopamine and acetylcholine?

Absolutely.

Think of it like a car's accelerator and brake.

In the motor system, dopamine is the primary inhibitory neurotransmitter.

It's the brake.

It smooths out movement.

Acetylcholine, on the other hand, is excitatory.

It's the accelerator.

It stimulates movement.

So in Parkinson's, we lose the brake.

You've lost the brake.

The dopamine -producing cells die off, so you have less and less dopamine.

This means the accelerator, acetylcholine, is running unopposed, uncontrolled.

And that's what leads to all the classic motor symptoms.

And you said symptoms don't show up until?

Until about 60 % of those dopamine neurons are already lost.

It's a huge deficit by the time we even make the diagnosis.

And the diagnosis really hinges on recognizing the four cardinal signs.

The acronym is TRAP.

Let's break those down.

Okay, so T is for tremor.

And it's a very specific kind of tremor.

It's slow.

It's rhythmic.

It usually starts on one side of the body.

And most characteristically, it's a resting tremor.

Meaning it goes away when they move.

It disappears, or at least gets much better, with purposeful movement or when they're asleep.

The classic look is that pill -rolling motion between the thumb and fingers.

Okay, T is tremor.

R is for rigidity.

Rigidity is that stiffness in the muscles.

It's a resistance to passive movement.

So when you, as the nurse, try to move the patient's arm, it might move in these short, jerky increments.

We call that cogwheel rigidity.

Or it could just feel stiff all the way through.

Right, like trying to bend a lead pipe.

That's the other type.

Okay, so TRA is for echinacea, or breadychinesia.

And you said this is often the most debilitating one.

It is, it's that overall profound slowing of all movement.

Patients will talk about the incredible frustration of the freezing phenomenon.

Or they're just stuck.

They're just stuck, they're trying to walk, and their feet feel like they're glued to the floor.

It affects everything, their shuffling gait, the difficulty turning over in bed, taking so much longer to just get dressed in the morning.

And the last letter P is for postural instability.

Right, this is the loss of those automatic postural reflexes that keep us balanced.

The patient develops that classic stooped, forward flexed posture.

They lose their balance very easily.

And that leads to that shuffling gait.

A short shuffling gait.

And often they'll start to speed up as they walk, like they're trying to catch up to their own center of gravity.

We call that propulsion.

And it puts them at a constant, extremely high risk for falls.

So beyond the big four, TRAP, what other common issues does a nurse have to manage with these patients?

Oh, there are many.

The autonomic dysfunction is huge.

You see excessive drooling, severe orthostatic hypotension, which is another fall risk, and incredibly stubborn chronic constipation.

And swallowing is a major problem.

A huge problem.

Dysphagia affects more than half of all patients, which puts them at a very high risk for aspiration pneumonia and malnutrition.

We also see the non -motor symptoms, like that expressionless mask -like face, the tiny cramp handwriting called micrographia, and a very soft monotone voice, which is dysphonia.

Let's get into PD management and the nursing process.

Pharmacologically, Luvodopa carbidopa is still the best drug we have.

But it comes with a ticking clock.

It really does.

It's the most effective drug because it's a precursor to dopamine.

It replaces what's missing.

But unfortunately, after about 5 to 10 years of use, its benefits start to wane.

And that's when major complications start to show up.

Right.

Two big ones.

First, you get those uncontrolled rhythmic movements we defined earlier, the dyskinesias.

And second, you get the unpredictable on -off syndrome.

Explain what that looks like for the patient.

It's like a light switch is being flipped.

The patient can cycle, sometimes rapidly within a single day, between periods where their medication is working and they have good mobility,

the on time and periods of severe immobility and stiffness when it's not, the off time.

So because of those long -term problems, the textbook says we often start with other drugs to try and delay using Luvodopa.

That's a common strategy.

We might use dopamine agonists early on, which stimulate the dopamine receptors directly.

We can also use drugs called COMT inhibitors.

And what do they do?

They block an enzyme that breaks down Luvodopa.

So they basically extend the time that the Luvodopa is effective.

It helps to smooth out some of those off periods.

Now, for patients who are more advanced, who still respond to Luvodopa, but are really disabled by the dyskinesias,

deep brain stimulation, DBS, has become a major option.

DBS has been truly transformative for the right patient.

As you can see in figure 65 to five, it involves implanting a very thin electrode deep into the brain, usually the globus politis or the subthalamic nucleus.

And that's connected to a pulse generator, like a pacemaker.

Exactly.

An implanted pulse generator sends continuous electrical impulses.

And those impulses disrupt the abnormal nerve signals that are causing the tremor and the rigidity.

Who's a good candidate for that?

The ideal candidate is someone who initially had a great response to Levodopa, so we know their dopamine pathways are still receptive, but who is now limited by the side effects.

They also need to have intact cognition.

Okay, now for the hands -on part,

nursing interventions.

Let's start with improving their mobility.

Daily progressive exercise is absolutely non -negotiable.

Walking, swimming, stretching, it's essential for reducing that rigidity and preventing contractures.

But we also have to teach them very specific walking techniques.

To overcome that shuffling and freezing.

Exactly.

You have to teach the patient to think about every step.

Walk, consciously erect, look up toward the horizon, not down at your feet.

And to take bigger steps.

Take bigger steps, exaggerate the heel -toe placement, and consciously swing your arms.

A great trick for breaking a freeze is to provide an external cue, like telling them to step over an imaginary line or even just walking to the beat of marching music.

And what about swallowing, given that high aspiration risk?

Aspiration is the constant threat.

The patient must be positioned fully upright for every meal.

Their diet should be semi -solid with thickened liquids.

Thin liquids are the most dangerous.

And you teach them to consciously swallow.

You do.

You break it down.

Close your lips, lift your tongue up and back, now swallow hard.

It becomes the deliberate conscious act instead of an automatic one.

And that chronic, awful constipation.

It's so severe.

It comes from the slowed gut motility and the medication side effects.

Management requires a very strict regular bowel routine, pushing fluids, moderate fiber, and a simple but incredibly helpful piece of equipment is a raised toilet seat.

Because it makes it easier to stand up.

Much easier.

It reduces the effort needed to overcome that bradykinesia and rigidity when they try to get up.

Finally, how do we support their coping and safety?

We want to encourage them to stay as active and involved in their own care as possible, setting small, achievable goals.

Safety is a continuous process.

While risk assessments have to be done all the time, and we have to monitor for the psychiatric side effects of the disease and the drugs hallucinations, paranoia, depression,

and manage those carefully.

Let's shift now to Huntington disease, HD.

This one is particularly devastating because it's genetic.

It is.

It's a textbook autosomal dominant disorder.

That means a child of a parent with Huntington's has a 50 % chance of inheriting the gene.

And it's defined by this classic triad of symptoms.

Motor, cognitive, and behavioral.

That's right.

And it's chronic and relentlessly progressive.

Let's talk about the pathophysiology and that hallmark motor sign.

Correa.

The pathology is the premature death of cells in parts of the brain called the striatum and the cortex.

And the most prominent symptom that results from that is the correa, those constant, rapid, writhing, twisting, uncontrollable movements.

That involves the whole body.

The whole body, the trunk, the limbs, the face.

The patient will often try to incorporate these involuntary movements into what looks like a purposeful act, but they are relentless.

They never stop when the person is awake.

And what does that mean for their daily life and their prognosis?

Eventually, the constant movement makes walking or even sitting still completely impossible.

Communication becomes slurred and then unintelligible.

And the risk of choking and aspiration is incredibly high.

Cognitively, it progresses to a profound dementia.

And the behavioral features, the anger, psychosis, depression.

That must be so hard on families.

Extremely difficult.

Profound depression is a major threat.

And the risk of suicide is very high, especially in the early stages when the patient still has insight into what's happening to them.

Since there's no cure, management is about optimizing their quality of life.

So because there's no cure, the nursing care is all about safety and support, as outlined in chart 65 to 4.

How do we manage that extreme risk for injury from the constant movement?

We have to physically protect the patient from their own body.

This means padding the bed rails, maybe even the headboard, using soft bedding.

The environment has to be free of clutter and sharp objects.

And nutritionally, they must be burning an incredible amount of calories.

A massive amount.

They can burn 4 ,000 to 5 ,000 calories a day.

But the Korea makes eating almost impossible.

But how do you feed them?

You have to gently stabilize their head while you're feeding them.

Use long -handled spoons.

Serve foods that are easier to swallow, like stews or thick liquids.

And a really crucial nursing insight here is that when they stiffen up or turn their head away, that's the Korea.

It's not them rejecting the food.

And you have to educate the family about that.

And what about communication?

You have to be proactive.

Get a speech therapist involved early to develop an alternative communication system picture boards, cards,

before their speech becomes completely unintelligible.

It's about maintaining that connection and their dignity.

OK, let's move into part three.

Further degenerative neurologic disorders, starting with ALS, amyotrophic lateral sclerosis.

Right, also known as Lou Gehrig disease.

This is the progressive destruction of motor neurons, both in the spinal cord and in the brainstem.

It leads to severe muscle atrophy and weakness.

It starts with fatigue and twitching, but eventually leads to total paralysis.

Total paralysis.

But what's really important to remember is what's spared.

So cognition is intact?

For most patients, cognition, sensation, vision, and hearing remain completely intact.

The anal and bladder sphincters are also usually spared.

But if the bulbar muscles of the face and throat are affected, they lose the ability to speak, swallow, and eventually to breathe.

So respiratory failure is the terminal event.

Yes, that and aspiration are what usually lead to death.

Since there's no cure, what do the main disease -modifying drugs, Riluzole and Edervone, actually do?

They may modestly slow the progression of the disease, extend survival by a few months, but most of our management is symptomatic.

We use drugs like baclofen for painful spasticity, and we have to be very aggressive in managing depression.

And respiratory care is the absolute highest priority?

The highest.

We use non -invasive positive pressure ventilation, like BiPAP, often at night, to support their breathing and try to postpone the need for tracheotomy.

And what about nutrition?

When is the right time to place a PEG tube?

We recommend placing a PEG tube early.

The guideline is to do it before the patient's forced vital capacity, their FVC, drops below 50%.

If you wait too long, the patient is already malnourished and the surgical risk is much higher.

And this is where advanced directors become so critical.

Absolutely profound.

The nurse has a huge role in initiating these conversations about end -of -life wishes, about mechanical ventilation, about feeding tubes early, while the patient is still fully capable of making their own autonomous decisions.

Let's briefly touch on muscular dystrophies.

Right, this is a whole group of inherited muscle disorders.

They all lead to progressive muscle weakening and wasting.

And again, since there is no cure, the care is entirely supportive.

So the main goals are preventing complications.

Exactly, preventing contractures with splints and stretching,

managing the spinal deformities that develop, sometimes with bracing or surgery.

And a critical thing to monitor for in many types of MD is cardiac failure from cardiomyopathy.

It's a very common complication.

Okay, next up is a really common problem.

Degenerative disc disease or DDD?

This is the root cause of so much chronic neck and back pain.

As we age, the intervertebral discs that cushion our spine lose water and get weaker.

And that's what leads to herniation.

Right.

Herniation is when the gooey center of the disc, the nucleus pulposus, pushes out through that weakened outer layer and that protrusion then compresses a spinal nerve root or the dural sac itself.

Which results in radiculopathy.

Radiculopathy.

That's the pain, numbness, or tingling that radiates along the path of that compressed nerve.

Let's start with cervical disc herniation.

Usually it's C5, C6, or C6, C7.

What are the signs?

The patient will complain of neck stiffness and a sharp radiating pain that goes down their arm and into their hand, often with paresthesia.

But a large central herniation is a much bigger deal.

Because it can cause myelopathy.

Exactly.

Myelopathy means the spinal cord itself is being compressed.

And that's an emergency.

It's an emergency because radiculopathy is nerve pain, but myelopathy is cord damage.

So the signs are bilateral weakness in both arms and legs, difficulty with fine motor skills, that needs immediate surgical attention to prevent permanent paralysis.

So after conservative management,

if surgery like a dissectomy is needed, what's the key post -op nursing care?

We are on high alert for complications.

We're watching for a developing hematoma or swelling at the incision, which can compress the airway or the spinal cord.

We're also watching for a dural leak, that serosanguineous drainage from the dressing.

And the home care instructions are very specific.

Very specific.

No neck rotation, no lifting more than 10 pounds.

And we have to teach them exactly how to care for their cervical collar, including how to wash their neck while lying flat to maintain alignment.

Okay, now let's go down to the lower back.

Lumbar disc herniation, usually L5S1.

The hallmark symptom here is low back pain with muscle spasms.

And of course, sciatica.

That classic pain shooting down the leg.

Right, radiating from the buttock all the way down the thigh and leg along the sciatic nerve.

And the pain gets worse with anything that increases pressure inside the spine, like coughing or straining.

Diagnosis is often confirmed with a positive straight leg raising test.

And the conservative management has really changed, hasn't it?

It has.

We used to put people on prolonged bed rest, but now we know that's counterproductive.

It just leads to deconditioning.

Now the focus is on physical therapy, weight reduction, heat, and massage.

And preoperative teaching is all about that log rolling technique.

Postoperatively, we're monitoring for vascular injury hemorrhage and for any new nerve root injury by repeatedly checking their sensation and motor strength in their legs.

And positioning is key.

Key.

They have to log roll with a pillow between their knees to keep the spine aligned.

And we discourage sitting as much as possible, except for using the toilet, because sitting puts the most strain on the lumbar spine.

And finally, let's touch on post polio syndrome, or PPS.

Yes, this is a late onset issue we see in polio survivors.

We're talking about new symptoms of weakness, fatigue, and muscle pain that show up decades, 15 to 40 years after their initial polio infection.

And the theory is that the nerves are just wearing out.

That's the leading theory.

The photo units the body created to compensate for the original damage just get overworked and start to degenerate with age.

Since there's no specific treatment, what's the nursing philosophy here?

It's all about maintaining well -being and most importantly, energy conservation.

So pacing themselves.

Exactly.

They have to be taught to plan their day, do the most demanding activities in the morning, and schedule mandatory rest periods to avoid overexertion.

We prioritize non -drug methods for pain like heat and cold.

And we have to monitor for associated risks.

Like obesity and sleep apnea.

High risk for obesity because they're more sedentary and a high incidence of obstructive sleep apnea.

And because of the reduced mobility, we also have to screen for low bone mass and osteoporosis.

Wow.

We have covered a huge amount of ground from acute oncologic crises all the way to that slow, chronic degenerative decline.

We really have.

And I think the essential takeaways for you, the learner, are pretty clear.

For the oncologic patient, you have to master the signs of increased ICP.

For the degenerative patient, you have to instantly recognize those specific motor deficits, the TRAP of Parkinson's, the Korea of Huntington's, and be absolutely rigorous about safety and aspiration prevention.

And for any spinal surgery patient.

It's the nursing process in action.

Consistent enforcement of log rolling,

diligent monitoring for those critical complications like CSF leaks, and incredibly detailed home care education.

The thread that connects all of it is our mandate to manage symptoms while maximizing our patient's function and their autonomy for as long as we can.

You know, this deep dive really shows that the nursing role goes so far beyond just giving medications.

For these patients facing such a progressive loss, the most profound thing we do is offer that continuous,

compassionate presence and proactively adapt the plan of care.

Precisely.

It's about honoring their autonomy, helping them adapt to these relentless physical losses, and really upholding their quality of life.

And we have to remember the immense burden this places on the family caregiver and support them just as much right up until the very end.

That's a powerful and comprehensive guide.

Thank you so much for walking us through this chapter.

It was my pleasure.

And thank you for joining the deep dive.

We'll see you next time.